What is the ticker symbol for Sagimet Biosciences?

Sagimet Biosciences trades under the ticker SGMT on NASDAQ.

What sector does Sagimet Biosciences operate in?

Sagimet Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SGMT in a portfolio?

PortView shows SGMT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Sagimet Biosciences (SGMT) Stock Analysis

NASDAQHealthcareBiotechnology

$10.60+0.90%

1-year price historyRange $4.55 – $10.86

52-week range$10.60

$4.50$11.15

What Sagimet Biosciences does

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Key metrics

Market cap

$345.20M

P/E (TTM)

-7.91

EPS (TTM)

$-1.34

Beta

3.40

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$8.43

200-day avg

$6.78

52-week high

$11.15

52-week low

$4.50

CEO

David Happel

ETFs linked to SGMT

Broad-market and Healthcare sector ETFs an investor holding Sagimet Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SGMT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SGMT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Sagimet Biosciences?: Sagimet Biosciences trades under the ticker SGMT on NASDAQ.
Which exchange is SGMT listed on?: SGMT is listed on NASDAQ.
What sector does Sagimet Biosciences operate in?: Sagimet Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SGMT in a portfolio?: PortView shows SGMT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.